A certain batch of anti-anxiety drug Xanax is being recalled following reports that federal regulators discovered a manufacturing issue tied to its proper dissolution in the body once ingested. This means that the drug did not dissolve at the standard rate and could cause health-related issues.
Widely prescribed for people dealing with anxiety disorders or panic attacks, the recall only covers one lot of Xanax XR (alprazolam) extended-release 3-milligram tablets packaged in 60-count bottles according to the FDA.
